Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
438 studies found for:    "Hemophilia"
Show Display Options
RSS Create an RSS feed from your search for:
"Hemophilia"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Bleeding Symptoms of Carriers of Hemophilia A and B
Condition: Hemophilia
Intervention:
2 Completed A Feasibility Study to Collect Data in Patients With Haemophilia
Condition: Hemophilia
Intervention: Other: Laboratory variables
3 Active, not recruiting Inhibitor Development in Patients With Hemophilia A Undergoing Surgery
Condition: Hemophilia A
Intervention:
4 Completed Study of a pd vWF/FVIII, Biostate®, in Subjects With Haemophilia A
Condition: Hemophilia A
Interventions: Biological: Biostate® [SP];   Biological: Biostate® [RP]
5 Completed Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A
Condition: Hemophilia A
Intervention: Drug: ReFacto AF
6 Completed Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery
Condition: Hemophilia A
Intervention: Drug: ReFacto
7 Completed Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A
Condition: Hemophilia A
Interventions: Drug: ReFacto;   Drug: Advante
8 Unknown  Turkish Acquired Haemophilia Registry
Condition: Acquired Haemophilia
Intervention: Drug: rFVIIIa, aPCC, FVIII, DDAVP, Azathioprine, Rituximab, Cyclosporin
9 Completed Study Evaluating rFIX; BeneFIX in Severe Hemophilia B
Condition: Hemophilia B
Intervention: Drug: BeneFIX
10 Completed Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use
Condition: Hemophilia B
Intervention:
11 Unknown  Musculoskeletal Function in Hemophilia
Condition: Hemophilia
Intervention:
12 Completed Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A Patients
Condition: Hemophilia A
Interventions: Biological: Moroctocog alfa ( AF-CC);   Procedure: Laboratory tests
13 Unknown  Quality of Life in Adult Patients With Severe Haemophilia in Turkey
Condition: Haemophilia
Intervention:
14 Recruiting Multicentre, Non-controlled, Prospective, Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A
Condition: Haemophilia A
Intervention: Biological: Optivate 500IU
15 Completed Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A
Condition: Hemophilia A
Interventions: Genetic: ReFacto AF;   Genetic: B-Domain deleted Recombinant Factor VIII;   Genetic: BDDrFVIII
16 Completed
Has Results
Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment
Condition: Hemophilia A
Intervention: Biological: Recombinant Factor VIII (Kogenate FS, BAY14-2222)
17 Completed Phase I/IIa Study of FIXFc in Hemophilia B Patients
Condition: Hemophilia B
Intervention: Drug: rFIXFc
18 Active, not recruiting A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
Condition: Hemophilia A
Intervention: Biological: BAY94-9027
19 Completed Canadian Hemophilia Prophylaxis Study
Condition: Severe Hemophilia A
Intervention: Biological: Recombinant Factor VIII (Advate/Helixate FS/KoegenateFS)
20 Recruiting Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A."
Condition: Hemophilia A
Intervention: Drug: Recombinant Factor VIII (Kogenate FS, BAY14-2222)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.